Utah Medical Products, Inc.
UTMD
$71.10
$0.390.55%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -7.00% | -4.43% | -5.83% | -12.35% | -16.64% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -7.00% | -4.43% | -5.83% | -12.35% | -16.64% |
| Cost of Revenue | -8.26% | -3.48% | -1.43% | -8.73% | -13.27% |
| Gross Profit | -6.07% | -5.11% | -8.88% | -14.89% | -18.99% |
| SG&A Expenses | 7.03% | 14.73% | 12.75% | 3.22% | -15.12% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -2.90% | 2.12% | 2.32% | -5.89% | -14.25% |
| Operating Income | -14.30% | -15.54% | -18.86% | -22.59% | -20.59% |
| Income Before Tax | -16.81% | -15.31% | -16.03% | -19.71% | -17.65% |
| Income Tax Expenses | -18.31% | -10.99% | -3.59% | 1.63% | -7.68% |
| Earnings from Continuing Operations | -16.46% | -16.28% | -18.65% | -23.83% | -19.68% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -16.46% | -16.28% | -18.65% | -23.83% | -19.68% |
| EBIT | -14.30% | -15.54% | -18.86% | -22.59% | -20.59% |
| EBITDA | -14.80% | -12.55% | -15.16% | -20.00% | -22.41% |
| EPS Basic | -12.16% | -10.54% | -11.94% | -17.33% | -13.76% |
| Normalized Basic EPS | -8.92% | -9.21% | -11.52% | -16.26% | -14.58% |
| EPS Diluted | -12.29% | -10.57% | -11.95% | -17.33% | -13.67% |
| Normalized Diluted EPS | -8.92% | -9.21% | -11.51% | -16.25% | -14.53% |
| Average Basic Shares Outstanding | -4.83% | -6.36% | -7.52% | -7.77% | -6.86% |
| Average Diluted Shares Outstanding | -4.83% | -6.36% | -7.52% | -7.77% | -6.93% |
| Dividend Per Share | 1.65% | 1.65% | 1.66% | 1.67% | 1.67% |
| Payout Ratio | 0.15% | 0.13% | 0.15% | 0.24% | 0.19% |